Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; Percepta Genomic Sequencing Classifier and Percepta Nasal Swab Test for lung cancer diagnosis; Envisia Genomic Classifier for diagnosing interstitial lung disease, including idiopathic pulmonary fibrosis; and Immunoscore Colon Cancer test for colon cancer diagnosis.
Veracyte stock last closed at $30.50, down 2.8% from the previous day, and has increased 55.85% in one year. It has overperformed other stocks in the Biotechnology industry by 1.33 percentage points. Veracyte stock is currently +54.74% from its 52-week low of $19.71, and -35.54% from its 52-week high of $47.32.
As of Apr 30, 2025, there are 77.94M VCYT shares outstanding. The market cap of VCYT is $2.38B. In the past 24 hours, 1.07M VCYT shares were traded.
How to Buy Veracyte Stock
Not sure how to invest in Veracyte stock? Here's how.
Choose where to buy Veracyte stock: You need to pick a stock brokerage, but don't worry - we've analyzed dozens of online stock brokerages and apps to help you figure out where to buy Veracyte stock.
Create a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
Deposit money your brokerage account: Select your payment method and add your information.
Research Veracyte stock: The Veracyte ticker symbol is VCYT. Is Veracyte stock a good investment? Should you buy shares of VCYT? How do VCYT's underlying business fundamentals look? Do top analysts think Veracyte is a good buy? Why has VCYT's stock price moved recently? (Hint: Our stock research website can help you figure out if VCYT is a good stock to buy).
Place your VCYT buy order: Decide if you will purchase VCYT shares at the current market price or use a limit order to purchase VCYT stock at a particular price.
Keep an eye on your VCYT position: Create a watchlist to get the latest news on your new investment in Veracyte stock.
Step 1: Choose where to buy Veracyte stock
You will need a brokerage account in order to access the NASDAQ market and buy VCYT stock.
A brokerage account is an investment account that allows you to buy and sell a variety of investments, such as stocks, bonds, mutual funds, and ETFs.
Our favorite brokerage: eToro
In our opinion, eToro is the best brokerage. eToro gives you:
Invest in stocks with 0% commissions: Invest without paying trading commissions.
Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
Access to world markets: From Technology to Financial Services, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top exchanges.
Social investing: eToro boasts a community of more than 20 million users globally. Talk to, learn from, and copy the crypto trades of other investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of shares by opening an account with eToro now. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Create a brokerage account
Now that you've chosen your brokerage, it's time to fill out some personal information so you can invest in VCYT today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Research Veracyte stock
After you have figured out the best place to buy Veracyte stock, it's critical to research their stock prior to investing, so you truly wrap your head around the risk and opportunity.
Veracyte shares at a glance
VCYT Price
$30.50
1w %
-3.07%
1y %
55.85%
5y %
13.09%
P/E
95.31x
P/B
2.02x
P/S
5.23x
PEG
1.48x
Revenue
$445.76M
Earnings
$24.14M
Fore. Rev. Growth
10.44%
Fore. Earn. Growth
71.34%
Market Cap
$2.38B
Next Earnings
May 5, 2025
Next Dividend
N/A
Fundamentals of Veracyte
WallStreetZen was designed to help average investors perform more accurate fundamental analysis quickly.
There are more short-term assets than long-term liabilities on the VCYT balance sheet.
VCYT's operating cash flow of $75.10M allows it to safely service it's debt of $50.74M.
Total VCYT debt is lower than 5 years ago, relative to shareholder equity.
VCYT has a low debt to equity ratio of 0.11.
VCYT profit margin has gone up from -20.6% to 5.4% in the past year.
VCYT earnings of $25.74M is not sufficient to cover its interest payments.
There are more short-term assets than short-term liabilities on the VCYT balance sheet.
Do analysts think it's a good time to buy VCYT stock
Out of 8 Equities analysts who give ratings on VCYT, the consensus analyst rating on Veracyte is a Buy
Please note that analyst forecasts are not stock recommendations, nor are they financial advice.
Most Recent VCYT Analyst Upgrades/Downgrades
Matthew Sykes, a top 8% analyst from Goldman Sachs downgrades VCYT to a hold rating and lowers their VCYT price target from $38.00 to $37.00, on Dec 5, 2024.
Tejas Savant, a bottom 7% analyst from Morgan Stanley maintains VCYT with a strong sell rating and raises their VCYT price target from $26.00 to $28.00, on Nov 18, 2024.
Sung Ji Nam, a bottom 5% analyst from ScotiaBank maintains VCYT with a buy rating and raises their VCYT price target from $40.00 to $44.00, on Nov 8, 2024.
Last year, VCYT revenue was $445.76M. During the past 5 year, VCYT's revenue has grown by 29.93% per year. This was slower than the Biotechnology industry average of 45.66%.
No, Veracyte doesn't provide an income stream by paying out dividends.
What others are saying about VCYT
One of the reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other investors have to say.
Step 5: Place your VCYT buy order
You have two primary order types:
Market order: A market order is an order to buy or sell a security at the best possible price. Market orders are generally sufficient.
Limit order: A limit order enables you to buy or sell a security at a specific price (or better). If you want to ensure you're buying or selling at a particular dollar amount limit, place a limit order.
Hit the Open button and eToro will execute the order.
If you require additional info about investing in stocks on eToro, click the how to video below:
As of Apr 30, 2025, it costs $30.50 to buy one share of Veracyte stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.328 shares of VCYT.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.